SCHEMBL22459611

SCHEMBL22459611

C=C(COC)C(=O)OCCCc1ccc(-c2ccc(-c3ccc(-c4ccc(CCCOC(=O)C(=C)COC)cc4)cc3F)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RARB P10826 4/20 0.43
▸ RARA P10276 2/20 0.40
▸ RARG P13631 1/20 0.40
▸ S1PR1 P21453 3/20 0.34
▸ S1PR3 Q99500 2/20 0.34
▸ PTGES O14684 1/20 0.34
▸ KDM1A O60341 2/20 0.33
▸ FDFT1 P37268 1/20 0.33
▸ FFAR1 O14842 1/20 0.33
▸ APP P05067 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ FFAR4 Q5NUL3 1/20 0.32
▸ HCAR2 Q8TDS4 1/20 0.32
▸ DGAT1 O75907 1/20 0.32
▸ SOAT1 P35610 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22459777 0.94 RARB (0.43) RARBRARARARGS1PR1S1PR3
SCHEMBL22459260 0.93 RARB (0.39) RARBRARARARGS1PR1S1PR3
SCHEMBL22459320 0.90 RARB (0.41) RARBS1PR1S1PR3PTGESKDM1A
SCHEMBL21422425 0.89 RARB (0.40) RARBRARARARGS1PR1PTGES
SCHEMBL22561079 0.88 LPAR1 (0.33) RARBRARARARGFFAR4TSHR
SCHEMBL22459329 0.87 RARB (0.36) RARBKDM1AFFAR4
SCHEMBL22459412 0.87 LMNA (0.40) RARBRARAMEN1ALDH1A1MAPT
SCHEMBL22459252 0.87 LMNA (0.40) RARBRARAMEN1ALDH1A1MAPT
SCHEMBL22459277 0.87 EGFR (0.37) RARB
SCHEMBL22459840 0.87 RARB (0.34) RARBRARARARGFFAR4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3725764-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE JNC Corporation (JP) 2020-10-21 — — EP disclosed
US-20200299578-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2020-09-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200299578-A1 POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, CCND1, CPNE4 RARB 3668/4885RARA 3532/4885RARG 4084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback